INDEX OF AUTHORS

Carassa, R., 91

Cioffi, G.A., 65

Coleman, A.L., 73

Crowston, J.G., 41

Fechtner, R., 9

Friedman, D.S., 65

Goldberg, I., 91

Grehn, F., 109

Greve, E.L., XIII

Gupta, N., 117

Heuer, D.K., 83

Hitchings, R., 9

Jampel, H.D., 117

Khaw, P.T., 41

Kim, J., 57

Liebmann, J.M., 57

Medeiros, F.A., 83

Minckler, D.S., 21

Palmberg, P., 1

Pfeiffer, N., 65

Ritch, R., 21

Sherwood, M.B., 41

Singh, K., 73, 131

Weinreb, R.N., XIII

Wells, A.P., 117

AUTHOR’S FINANCIAL DISCLOSURE RELATING TO PRODUCTS DISCUSSED IN THEIR CHAPTERS

Carassa, R., none Cioffi, G.A., none Coleman, A.L., none Crowston, J.G., none Fechtner, R., none Friedman, D.S., none Goldberg, I., none

Grehn, F., Cambridge Antibody Technologies – research funding Gupta, N., none

Heuer, D.K., none Hitchings, R., none Jampel, H.D., none

Khaw, P.T., Cambridge Antibody Technologies – research funding, paid consultancy; Polytherics – research funding

Kim, J., none Liebmann, J.M., none Medeiros, F.A., none Minckler, D.S., none Palmberg, P., none Pfeiffer, N., none Ritch, R., none

Sherwood, M.B., Cambridge Antibody Technologies – research funding Singh, K., 73, none

Weinreb, R.N., none Wells, A.P., none